Varex to Highlight Advanced Imaging Components at Medica in Dusseldorf
Varex Imaging Corporation (Nasdaq: VREX) today announced it will showcase its digital detectors, X-ray imaging tubes, connect and control devices and software solutions at Medica 2019. Medica is attended by leaders in the fields of business and research, and international experts and decision-makers from the medical sector covering the entire spectrum of innovations for outpatient and clinical care.
Varex will also promote its ‘Local for Local’ campaign at Medica 2019 and introduce the company’s Service Solutions Group, which has been developed to provide local service to our customers with increased local X-ray tube and digital detector manufacturing and the aim of being global partners for local business.
“Our aim is to bring innovative X-ray imaging components to imaging systems manufacturers and we want to make that as easy as possible for our customers. By establishing local commercial relationships, delivering local service and support, and sourcing from local suppliers, we can be a global company and offer enhanced service capability that is local, hands-on, responsive, and easy to reach,” said Sunny Sanyal, Chief Executive Officer of Varex Imaging Corporation.
At Medica 2019, Varex will be highlighting its service and support and European customer experience by:
- enabling on-time delivery for common X-ray tube types in the radiological range of key brands
- providing technical support, evaluations and repairs of Varex digital detector flat panels/X-ray tubes at the company’s service centre in Willich, Germany
- giving access to local expert technical support for CT software, Nexus trainings and inquiries about X-ray detectors and tubes
Varex will be displaying a selection of their extensive portfolio of real-time digital X-ray imaging flat panel detectors (FPDs) at Medica 2019. Varex FPDs are developed using a variety of imaging technologies – amorphous silicon, CMOS and IGZO, which provide different benefits ideally suited to specific medical applications. For Surgery, Varex is showcasing 2020DXV/2121DXV and 3030DXV which are cost-efficient, high performance panels for Image Intensifier replacement. The company is also introducing the Varex Z platform which offers a new performance level with higher resolution and improved low dose performance over Amorphous Silicon, but without the cost burden of CMOS. Varex Z platform is based on IGZO technology and is very suitable for fluoroscopy applications with their bright scintillators, new electronics and fast interfaces. For Radiography, Varex will be showcasing its complete range of high value (2530W, 4336Wv4, 4343W) and high definition (XRpad2 3025, XRpad2 4336, XRpad2 4343) wireless panels. The Varex team of imaging experts will be on hand at Medica 2019 to advise customers on technology and packaged component solutions that are most suitable for their application; be it Radiography, Mammography, Fluoroscopy or Computed Tomography (CT). Varex Imaging will be providing Solutions in Sight™ at Medica 2019.
At Varex, we aren’t just a supplier to our customers. We aim to be an extension of their teams; a partner in their success; a solution to their problem. Our goal is to enable our customers to become world-class system suppliers by strengthening their competitiveness and enabling them to bring products to market faster. Our rich history spans 65+ years of dedication to the imaging industry. Our knowledge, our people, and our innovation make us who we are. At Varex, we are Solutions in Sight™.
For more information about Varex visit: www.vareximaging.com.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HighRes Biosolutions and Novo Nordisk partner to transform drug discovery in automated Lab of the Future24.1.2020 17:00:00 EET | Press release
HighRes Biosolutions and Novo Nordisk A/S today announced that they will collaborate to design a state-of-the-art robotic platform for high-throughput biologics engineering and characterisation. The integration of a multi-system robotics platform with sophisticated software control architecture will enable a digital transformation and accelerated discovery for Novo Nordisk’s peptide and large molecule therapeutics research. “In order to maintain our leadership within biologics engineering we are investing in a fully automated and digital design platform. This investment is linked to our build-up in AI and advanced analytics and demonstrates Novo Nordisk’s commitment as a world leading biologics research company,” said Lars Fogh Iversen, senior vice president, Global Research Technologies, Novo Nordisk. The platform will comprise several highly automated and integrated cells for production, characterisation and functional analysis of thousands of biologic compounds every month. Its scop
Conquest Invests in 5 Greenfield Onshore Wind Parks Totalizing 43MW in the Flanders Region24.1.2020 15:37:00 EET | Press release
Conquest, acting through the Conquest Sustainable Infrastructure fund, announced the transaction was closed after an exclusive agreement had been reached with ENGIE Electrabel. Conquest acquires 51% of a portfolio expected to provide 111 GWh per annum of renewable power representing the annual electricity consumption of about 32,000 Belgian homes from early 2021 onwards. The projects benefit from 15 to 20-year green certificates local remuneration schemes, and thus generate yearly secured revenues. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200124005221/en/ Credit: Electrabel While the energy and digital transitions continue to drive the infrastructure sector, Conquest keeps building its diversified sustainable real asset portfolio in Western European markets. The success lies in years of collaboration and long-lasting partnerships with fellow industry experts who can notably facilitate access to new growth opportunities
Fluence Expands EMEA Footprint with Horticulture Partners in Papenburg, Germany24.1.2020 14:00:00 EET | Press release
Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and agriculture production, announced today it is expanding its presence in the Emsland region of Germany through partnerships with growers and other horticulture specialists operating out of Papenburg. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200124005109/en/ Friedrich Schulz’s 5.5 hectare farm—which grows herbs year-round in addition to lettuce, peppers and chives—utilizing VYPR 2p fixtures. (Photo: Business Wire) Given Papenburg’s decades-long history of attracting horticulture experts, Fluence’s innovative lighting solutions for horticulture are a natural fit for the region’s tomato, cucumber, leafy greens and herb growers. Forging connections with Papenburg’s horticultural leaders Elektro Evers, an engineering firm specializing in greenhouse technology, is Fluence’s exclusive systems integrator
HCL Technologies Honors Global Goodwill Champions at the 2020 World Economic Forum in Davos24.1.2020 12:47:00 EET | Press release
HCL Technologies (HCL), a leading global technology company, today presented its Wave Maker Awards 2020, commemorating global goodwill champions from around the world. The award ceremony, which was held at the HCL Pavilion in Davos, celebrated organizations and individuals passionately committed to such noble causes as diversity & inclusion, education & community upliftment, environment & sustainability, and technology for change. Special guest at the awards was Australian cricket legend Glenn McGrath, who is also founder of the McGrath Foundation, which provides support for Australian women diagnosed with breast cancer and their families. The award recipients were; Lois Auta, Founder and Executive Director of Cedar Seed Foundation, which supports persons with disabilities to participate in all aspects of life; Chido Govera, Founder and Director of The Future of Hope Foundation (TFoHF), which supports marginal and vulnerable members of society through entrepreneurial and self-developme
Ipsen’s palovarotene clinical program in fibrodysplasia ossificans progressiva reaches prespecified interim analysis futility criteria24.1.2020 09:00:00 EET | Press release
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the decision to pause dosing patients in the global Phase III (PVO-1A-301) study designed to evaluate the efficacy and safety of palovarotene in patients with fibrodysplasia ossificans progressiva (FOP), as well as the ongoing Phase II (PVO-1A-202/204) extension studies. In both the Phase III and Phase II extension studies, palovarotene is dosed both chronically (daily) and episodically (during flare-ups). The decision to pause dosing patients in the trial is based on results of a futility analysis reviewed by the Independent Data Monitoring Committee (IDMC) as part of the prespecified interim analysis. The results of a futility analysis indicated that the Phase III FOP trial was unlikely to meet its primary efficacy endpoint (annualized change in new HO volume as compared with Natural History Studyi) upon completion. Despite the results of the prespecified interim analysis, signals of encouraging therapeutic activity w
Amazentis Announces the Launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos23.1.2020 23:56:00 EET | Press release
Amazentis announces the debut of Timeline, a next generation nutrition product designed to promote healthy aging, as part of the Swiss Food & Nutrition Valley in the House of Switzerland at the World Economic Forum in Davos, Switzerland. Given the increase in the aging population globally -- according to a 2019 Deutsche Bank study, there are more people on Earth older than sixty five than younger than five for the first time -- it is imperative for consumers to take proactive measures to maintain a high quality of life, for as long as they live. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200123005820/en/ (Photo: Business Wire) Timeline contains the proprietary nutrient Mitopure™, a highly pure form of Urolithin A. After a decade of rigorous research by leading scientists around the world, Mitopure has been shown to help counter age-associated cellular and muscular decline by revitalizing the mitochondria, the powerplants
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom